Collexis' Expert Profiling for the UK's Biomedical Research Community

Collexis Holdings, Inc.A new agreement was announced between Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic knowledge discovery software and expert profiles, and JISC Collections for an online resource, which aims to encourage greater collaboration and expand scientific knowledge amongst the biomedical research community in the UK. For specially negotiated subscription fees, researchers, teaching staff and students at universities and research councils in the UK, will be able to access Collexis' Expert Profiling. This online resource enables users to quickly identify experts within their institution as well as identify, locate and collaborate with other experts from around the world.

Using the Collexis system, subscribing institutions can create expert profiles of investigators, researchers and departments to disseminate ground-breaking research and biomedical advances. These profiles are generated using researchers’ publications from a variety of sources. Profiles are then available to all researchers, allowing them to easily find what is being published, what researchers are active and the pace of research in a particular area of interest.

"Collexis' Expert Profiling System fosters collaboration among researchers, allowing them to leverage the information of their colleagues and work to enhance, stimulate and create new ideas and discoveries," said Bill Kirkland, CEO of Collexis Holdings, Inc. "We are excited about working with JISC Collections to create internal expert profiling systems that bridge the gap between departments, cooperating organisations, basic research and clinical research."

Lorraine Estelle, CEO of JISC Collections, says that this agreement will "save users researchers time identifying expertise within their institutions, but provides opportunities for research and help widen access to essential sources of biomedical research. We also hope that it will encourage greater collaboration across our community through increased awareness and through the sharing of research outputs amongst institutions."

In addition to the new agreement with JISC Collections, Collexis Holdings Inc. is bringing its innovative technology to other research organisations and universities worldwide, including the Mayo Clinic Libraries; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Bristol-Myers Squibb; Lockheed Martin; World Health Organization, National Institutes of Health; and U.S. Department of Defense.

Collexis' Expert Profiling is available to all staff and students within a subscribing university or research council institution in the UK. Institutions wanting access to the service will be required to pay an annual subscription fee. For further information, please go to: http://www.jisccollections. ac.uk/catalogue/collexis_expert.

Related news articles:

About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks". Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

About JISC Collections
JISC Collections was established as a mutual trading company by the UK further and higher education funding councils in 2006 to negotiate with publishers of online information and other owners of digital content. The range of resources licensed for use by such agreements constitutes a large national collection of online resources for education and research. JISC Collections is funded by JISC. For further information, please go to http://www.jisc-collections.ac.uk.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...